Summary
Machine-generated summaryKlinikum Chemnitz gGmbH is procuring a concept and solution for Next Generation Sequencing for its Institute of Pathology in Chemnitz, Germany, where around 400 to 500 tumour marker sequencing runs are performed annually and volumes are expected to rise to 650 to 700. Requirements include DNA and RNA analysis from FFPE and liquid biopsy, over 500 biomarkers, WES sequencing, an open fully automated system, and three references proving expertise. The procedure is a negotiated procedure.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profileWho usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| RaySearch Germany GmbH | 1 | €1.8M | Jan 2026 |
| Hanse-Medizintechnik; medika Medizintechnik GmbH; Hammerlit; AKULA Medizintechnik GmbH; Medtronic GmbH; Kusch + Co DK Sachsen; TapMed Medizintechnik Handels GmbH; AMEDTEC MEdizintechnik Aue GmbH | 1 | n/a | Dec 2025 |
Based on 2 awards with a linked company profile over the last 5 years.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Read before bidding
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
3
days left
€2,750,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,113,906
- Buyer track record on Aperlena
- 6 notices tracked · 3 awarded
- €2,659,360 in awarded contracts
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert